Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-03-24

Clinical Trial Update: Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

View source ↗

Summary

An update on a clinical trial examining whether recombinant growth hormone therapy affects intraocular pressure in individuals with glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Growth Hormone Treatment, Glaucoma | Status: UNKNOWN